跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anastragen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Anastragen
Approved
STANDARD
Anastragen
Remedica Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d564e8408e997ed9
Company
Remedica Ltd.
Type
Standard
Approval Details
Approval Id
d564e8408e997ed9
Drug Approval Philippines Name
Anastragen
Product Name
Anastragen
Registration Number
DRP-7878-01
Brand Name
Anastragen
Generic Name
Anastrozole
Dosage Form
Film-Coated Tablet
Dosage Strength
1 mg
Manufacturer
Remedica Ltd.
Issuance Date
23 September 2024
Expiry Date
10 April 2028
Pharmacologic Category
Endocrine Therapy (Aromatase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d564e8408e997ed9
Type
Standard
Back to Philippines FDA Approvals